NHC Responds to CMS CY 2027 OPPS Proposed Rule August 31, 2026 Mehmet Oz, MD, MBA AdministratorCenters for Medicare & Medicaid Services Department of Health and Human Services 7500 Security […]
Reducing Health Costs
NHC Response to 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft
NHC Response to 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft August 28, 2026 The Honorable Bill Cassidy Chairman Committee on Health, Education, Labor, and Pensions United […]
NHC Comments on OIG Clinical Trial Participation RFI
NHC Comments on OIG Clinical Trial Participation RFI August 24, 2026 The Honorable T. March Bell Inspector General Office of Inspector General Department of Health and Human Services Cohen Building […]
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029 August 17, 2026 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of […]
NHC Responds to Senate RFI on Drug Costs
NHC Responds to Senate RFI on Drug Costs August 17, 2026 The Honorable Ron Wyden Ranking Member Committee on Finance United States Senate Washington, DC 20510 Dear Ranking Member Wyden: […]
NHC’s Comments on the CMS Proposed Rule on Interoperability and Prior Authorization
NHC’s Comments on the CMS Proposed Rule on Interoperability and Prior Authorization June 15, 2026 Dr. Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of Health […]
Putting Patients First in the 2026 Policy Landscape
Putting Patients First in the 2026 Policy Landscape As Congress and the Administration advance and implement health care policies that could reshape access to care, affordability, public health, research, and innovation, […]
Supporting Patient Voices in the Next Round of Drug Price Negotiations
Supporting Patient Voices in the Next Round of Drug Price Negotiations By Allen Pinn, Manager, Policy & Jennifer Dexter, Vice President, Policy As the next cycle of drug negotiations begins […]
CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D
CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D By: Allen Pinn, Coordinator, Policy The Centers for Medicare and Medicaid Services (CMS) released a proposed rule […]
NHC Updates Health Care Cost Policy Recommendations
NHC Updates Health Care Cost Policy Recommendations By Eric Gascho, Vice President, Policy and Government Affairs One of the biggest barriers to access and health equity is the rising cost […]